IRVING, Texas, Jan. 5 /PRNewswire-FirstCall/ -- RBC Life Sciences
announced today that it has elected current president, John W. Price,
to CEO effective January 1, 2009. Company founder, Clinton Howard, who
is currently CEO, will remain as chairman of the board of directors.
promotion comes at a time when RBC Life Sciences, a global provider of
proprietary nutritional supplements, wound care and pain management
products, is growing domestically and internationally. The company
announced recently that third quarter net sales and earnings both
increased 26 percent over the same period last year.
possesses the perfect skill set to take RBC Life Sciences to the next
level," said Mr. Howard, who founded the company in 1991. "He has the
vision, leadership and focus needed to pilot a multinational company to
the forefront of its industry."
retired U.S. naval commander, Price was named president of RBC Life
Sciences in December 2007. He will retain the position of president
after being promoted to CEO January 1. Prior to joining the company, he
served as a senior executive for two major companies that market
nutritional supplements domestically and internationally. Price also
led a successful management consulting company and spent 17 years as a
senior officer of pharmaceutical giant Eli Lilly.
an exciting time for RBC Life Sciences," said Price, a triathlon
athlete who practices the healthy nutrition and exercise promoted by
the company. "We're redoubling our efforts to grow our North American
market while undertaking aggressive international expansion. We have a
healthy balance sheet driven by sales of nutritional supplements and
medical device products that are backed by science and are receiving
increasing accolades within their industries."
The company's medical devices brand, MPM Medical Inc.,
is growing strongly. Sales of MPM's evidence-based prescription and
non-prescription wound care and pain management products increased 42
percent during the third quarter of 2008 compared to the same period
last year. The Kroger Co. began carrying some of MPM's products in its
1,900 pharmacies nationwide in March 2008. The public may purchase MPM
products directly from the company's Web site: www.mpmmedicalinc.com.
his previous company, Carrington Labs, Mr. Howard assembled the team of
scientists responsible for discovering the most-active compound
responsible for the renowned health-giving benefits of the aloe vera
plant. He leaves a 50-year legacy that has touched lives around the
world. Some of his many career milestones include serving as founding
president of the hospital now named Baylor Medical Center at Irving,
creating the nation's first network of clinical laboratories in the
1960s and founding RBC Life Sciences, a company whose products are
receiving worldwide critical acclaim.
been a humbling journey," said Mr. Howard. "An impetus for much of what
I've tried to accomplish in my personal and business life follows the
adage: 'It doesn't have to be this way.' You don't have to settle for
status quo when it comes to helping others."
About RBC Life Sciences
Life Sciences develops, manufactures and markets high-quality
nutritional supplements and personal care products to a growing
population of consumers seeking wellness and a healthy lifestyle. Under
its MPM Medical brand, RBC Life Sciences also develops and markets to
health care professionals in the United States proprietary prescription
and nonprescription products for advanced wound care and pain
management. All products are tested for quality assurance in-house, and
by outside independent laboratories, to comply with regulations in the
U.S. and in more than thirty countries in which the products are
distributed. For more information, visit the Company's Web site at www.rbclifesciences.com.
statements above, other than statements of historical fact, may be
forward-looking. Actual events will be dependent upon a number of
factors and risks including, but not limited to, changes in plans by
the Company's management, delays or problems in production, changes in
the regulatory process, changes in market trends, and a number of other
factors and risks described from time to time in the Company's filings
with the Securities and Exchange Commission.
SOURCE: RBC Life Sciences
Web site: http://www.mpmmedicalinc.com/